A61P 21/02
Muscle relaxants
Official title: Muscle relaxants, e.g. for tetanus or cramps
A61P21/02 (Muscle relaxants) appears on 3,460 US grants and 4,967 published applications in this corpus.
Search patents in A61P- Granted patents
- 3,460
- Published applications
- 4,967
- Assignees
- 1,596
- Inventors
- 8,176
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 9 | 0 |
| 1978 | 16 | 0 |
| 1979 | 13 | 0 |
| 1980 | 7 | 0 |
| 1981 | 6 | 0 |
| 1982 | 5 | 0 |
| 1983 | 5 | 0 |
| 1984 | 5 | 0 |
| 1985 | 4 | 0 |
| 1986 | 6 | 0 |
| 1987 | 5 | 0 |
| 1988 | 8 | 0 |
| 1989 | 7 | 0 |
| 1990 | 8 | 0 |
| 1991 | 8 | 0 |
| 1992 | 11 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 8 | 0 |
| 1996 | 9 | 0 |
| 1997 | 21 | 0 |
| 1998 | 13 | 0 |
| 1999 | 26 | 0 |
| 2000 | 24 | 0 |
| 2001 | 47 | 24 |
| 2002 | 49 | 80 |
| 2003 | 67 | 137 |
| 2004 | 74 | 225 |
| 2005 | 66 | 165 |
| 2006 | 111 | 170 |
| 2007 | 73 | 182 |
| 2008 | 88 | 210 |
| 2009 | 95 | 257 |
| 2010 | 146 | 351 |
| 2011 | 184 | 297 |
| 2012 | 200 | 336 |
| 2013 | 230 | 260 |
| 2014 | 224 | 300 |
| 2015 | 216 | 296 |
| 2016 | 205 | 318 |
| 2017 | 199 | 248 |
| 2018 | 203 | 196 |
| 2019 | 195 | 250 |
| 2020 | 168 | 158 |
| 2021 | 114 | 145 |
| 2022 | 73 | 100 |
| 2023 | 74 | 70 |
| 2024 | 53 | 92 |
| 2025 | 48 | 67 |
| 2026 | 24 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical composition for treating amyotrophic lateral sclerosis25 Aug 2026US 12,714,727 B2Nipro Corporation
- Nucleic acid drug suppressing production of myostatin gene MRNA30 Jun 2026US 12,668,796 B2Knc Laboratories Co., Ltd.
- Compounds and methods for treating spasticity9 Jun 2026US 12,648,939 B2Lexicon Pharmaceuticals, Inc.
- Fc region variant2 Jun 2026US 12,643,937 B2Chugai Seiyaku Kabushiki Kaisha
- Topically administered strontium-containing complexes for treating pain, pruritis and inflammation26 May 2026US 12,636,311 B2Galleon Labs LLC
- Imidazolium salt macrocyclic compound and preparation method therefor and use thereof8 Oct 2026US 2026/0308175 A1Fudan University
- Transdermal drug delivery patch system for controlled and sustained delivery of tizanidine base10 Sep 2026US 2026/0263383 A1
- Fc region variant27 Aug 2026US 2026/0250360 A1Chugai Seiyaku Kabushiki Kaisha
- Method for controlling membrane potential-dependent ion channel through type i taste receptors (t1rs)20 Aug 2026US 2026/0240820 A1Ion Chat Research Corporate
- Composition comprising recombinant clostridium neurotoxin20 Aug 2026US 2026/0240963 A1Ipsen Bioinnovation Limited
Most cited
By later US patents
- Modular infusion device and method1,554US 6,749,587 B2Insulet Corporation · 2004
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Biodegradable botulinum toxin implant657US 6,506,399 B2Allergan Sales, Inc. · 2003
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003